# Workflow 4: High-Throughput Platform for Silent Cluster Elicitors

**Paper**: "High-throughput platform for discovery of elicitors of silent bacterial gene clusters"

## Research Objective

- Develop systematic approach to identify small molecule activators of silent clusters
- Enable drug discovery from currently inaccessible biosynthetic potential
- Create platform for rapid elicitor discovery

## Computational Workflow

### STEP 1: Elicitor Library Design

**INPUT**: 
- Silent BGC genomic information
- Known elicitor molecules and mechanisms (reference)
- Target activation phenotype

**PROCESS**:
- Computational diversity analysis of potential activators
- Structural feature optimization for BGC activation potential
- Library size optimization for screening feasibility
- Chemical space exploration
- Diversity metrics calculation

**OUTPUT**: 
- Designed diverse elicitor small molecule library
- Library size and composition specifications
- Structural diversity metrics
- **Feeds into**: High-throughput screening design

---

### STEP 2: HTS Plate Design and Data Analysis Pipeline

**INPUT**: 
- Elicitor library from Step 1
- Silent cluster specifications

**PROCESS**:
- Experimental design optimization
- Statistical analysis method specification (robust z-score, etc.)
- Hit selection criteria definition
- Quality control specifications
- Data quality metrics

**OUTPUT**: 
- HTS protocol specifications
- Data analysis pipeline design
- Statistical thresholds for hit selection
- **Feeds into**: Screening execution

---

### STEP 3: Screening Data Analysis

**INPUT**: 
- HTS screening results
- Positive and negative controls

**PROCESS**:
- Data normalization and quality assessment
- Hit identification and ranking
- Dose-response analysis for confirmed hits
- Statistical validation of results
- Confirmation assay design

**OUTPUT**: 
- Identified elicitors for specific silent clusters
- Ranked by activation strength
- Dose-response characteristics
- **Feeds into**: Metabolite identification

---

### STEP 4: Metabolite Identification from Activated Clusters

**INPUT**: 
- Activated cultures with confirmed elicitors
- Mass spectrometry and NMR capabilities

**PROCESS**:
- Differential metabolomics data analysis
- Mass spectrometry feature extraction and annotation
- Structural elucidation support via NMR prediction
- Metabolite database searching
- Novel compound confirmation

**OUTPUT**: 
- Identified elicitors for specific silent clusters
- Novel bioactive compounds from previously inaccessible BGCs
- Chemical structure confirmation

---

## Final Experimental Product

**Validated elicitors and products** with:
- Small molecule activators of silent clusters
- Novel bioactive compounds discovered
- High-throughput screening platform established
- Ready for drug development pipeline

## Key Computational Tools

- Library design: Molecular descriptor tools, chemoinformatics libraries
- Cheminformatics: RDKit, Open Babel
- HTS data analysis: Spotfire, CDD Vault
- Statistical analysis: R, Python (scipy, pandas)
- Mass spectrometry: MZmine, XCMS
- NMR prediction: NMRdb, spectral prediction tools
- Metabolite database: HMDB, PubChem, ChEMBL
